Knoxville / Tennessee / United States
Provectus Pharmaceuticals specializes in the development of oncology and dermatology therapies. Operational for more than five years, the company has developed several intellectual properties and technologies in the areas of imaging, biotechnology and medical device. Its division, Provectus Pharmatech, is engaged in the development of drugs that are designed to selectively target and destroy cancer cells without harming surrounding healthy tissues. Provectus Pharmaceuticals has received an orphan drug designation from the Food and Drug Administration for its melanoma indication. It focuses on the treatment of melanoma and breast and liver cancers. The company also provides over-the-counter, skin care and personal hygiene products through its various divisions.
